The National Community Pharmacists Association applauded the Senate for passage of S. 2554, the Patient Right to Know Drug Prices Act, saying the legislation will prohibit "gag clauses" in private health plans.
NACDS praised The Patient Right to Know Drug Prices Act (S. 2554), which is part of the effort to empower pharmacists to help patients lower out-of-pocket drug costs.
Drug Store News sat down with Christie Welton, clinical executive at Elsevier, who discussed the company's role in helping simplify the time-consuming obstacle of drug database updates.
The Food and Drug Administration has approved an opioid analgesic risk and evaluation and mitigation strategy as part of a broader set of measures to address the opioid crisis.
Azova announced that Ashton Maaraba, the former head of the product and partners team at eRx network, has been named its new senior vice president of sales and operations.
